[ASND] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
27-Apr-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -9.48%
YoY- -49.33%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 95,894 137,702 48,034 47,393 33,589 22,896 15,290 239.70%
PBT -128,527 -81,088 -161,578 -121,862 -109,617 -202,069 -169,122 -16.70%
Tax 2,508 5,790 645 -429 1,297 5,349 -167 -
NP -131,035 -86,878 -162,223 -121,433 -110,914 -207,418 -168,955 -15.57%
Tax Rate - - - - - - - -
Total Cost 226,929 224,580 210,257 168,826 144,503 230,314 184,245 14.88%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -136.65 -63.09 -337.73 -256.23 -330.21 -905.91 -1,105.00 -75.14%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -2.30 -1.53 -2.88 -2.16 -1.98 -3.70 -3.03 -16.77%
EPS Diluted -2.30 -1.53 -2.88 -2.16 -1.98 -3.70 -3.03 -16.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.